Crossmark

Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma

Published Online: 2019-02-27

Authors

Blum, Agnieszka

Haussmann, Katy

Streitz, Mathias

Schlickeiser, Stephan

Tietze-Buerger, Carola

Blau, Igor Wolfgang

Uharek, Lutz
License Information

Text and Data Mining valid from 2019-02-27

Version of Record valid from 2019-02-27
More Information

Article History

Received: 30 April 2018

Accepted: 24 January 2019

First Online: 27 February 2019

Competing Interests

: The authors declare no competing interests.

Document is current